Company Filing History:
Years Active: 2020-2023
Title: Razwan Hanif: Innovator in Antibody Technology
Introduction
Razwan Hanif is a notable inventor based in Slough, GB. He has made significant contributions to the field of antibody technology, holding a total of 4 patents. His work focuses on enhancing the efficacy of recombinant antibody molecules, which are crucial in various therapeutic applications.
Latest Patents
Among his latest patents, Razwan has developed a method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species. This invention provides a method for enhancing the monomer content in a composition of recombinantly expressed antibody molecules. The method involves a thermal conversion step at temperatures ranging from 30 to 60°C, performed in the presence of a reducing agent. Another significant patent is the method of monomerisation of recombinant antibody molecules, which also aims to increase the monomer percentage. This method includes treating the composition with a denaturant, such as urea or Guanidine hydrochloride, and is similarly conducted in the presence of a reducing agent.
Career Highlights
Razwan has worked with prominent companies in the biopharmaceutical sector, including UCB Biopharma Sprl and UCB Biopharma Srl. His experience in these organizations has allowed him to refine his expertise in antibody development and innovation.
Collaborations
Throughout his career, Razwan has collaborated with notable colleagues, including Sam Philip Heywood and Gavin Barry Wild. These partnerships have contributed to his success and the advancement of his research in antibody technology.
Conclusion
Razwan Hanif is a distinguished inventor whose work in antibody technology has led to significant advancements in the field. His innovative methods for enhancing recombinant antibody molecules demonstrate his commitment to improving therapeutic solutions.